83 results
8-K
EX-2.1
SRGAQ
Surgalign Holdings, Inc.
29 Sep 23
Bankruptcy or Receivership
4:15pm
’ digital health strategy.
On February 28, 2023, Xtant acquired 100% of the issued and outstanding equity of Surgalign SPV, Inc. from the Debtors
8-K
EX-99.1
SRGAQ
Surgalign Holdings, Inc.
1 Aug 23
Surgalign Successfully Completes Auction and Names Successful Bidders For Asset Sales
5:19pm
with respect to its digital surgery strategy; (vii) the reliability of our supply chain; (viii) our ability to meet obligations, including purchase minimums
8-K
EX-99.1
SRGAQ
Surgalign Holdings, Inc.
23 Jun 23
Surgalign Receives NASDAQ Delisting Notice Following its Chapter 11 Filing
8:30am
with respect to its digital surgery strategy ; (vii) the reliability of our supply chain; (viii) our ability to meet obligations, including purchase
8-K
EX-99.1
SRGAQ
Surgalign Holdings, Inc.
20 Jun 23
Entry into a Material Definitive Agreement
8:48am
to identify, develop and successfully implement its strategic initiatives, particularly with respect to its digital surgery strategy; (vii) the reliability
8-K
SRGAQ
Surgalign Holdings, Inc.
16 Jun 23
Cost Associated with Exit or Disposal Activities
6:07pm
,” “estimates,” “requires,” “hopes,” “assumes” or comparable terminology, or by discussions of strategy. These forward-looking statements are based on current … strategy; (x) the reliability of our supply chain; (xi) our ability to meet obligations, including purchase minimums, under our vendor and other agreements
8-K
EX-99.1
pev mietrm1wk1dle22x
11 May 23
Surgalign Announces First Quarter 2023 Results and Provides Update on its Business Operations
4:06pm
8-K
2xjwbqb4vi29nruyg
13 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
8-K
EX-99.1
kxjn8
30 Mar 23
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 Results
4:06pm
8-K
EX-3.1
dqltf9ld itoely4
22 Dec 22
Amendments to Articles of Incorporation or Bylaws
3:43pm
424B3
p6hdw5iqyo4ie3
16 Nov 22
Prospectus supplement
4:26pm
424B3
sa58fh4w
16 Nov 22
Prospectus supplement
4:23pm
424B5
483e0tuneol091q dm
15 Nov 22
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
xhcvd169unmd
15 Nov 22
Surgalign Announces $12.0 Million Registered Direct Offering
4:05pm
8-K
q9pabhwjvs
9 Nov 22
Cost Associated with Exit or Disposal Activities
8:30am
8-K
EX-99.1
xxkuhz6puc8 vrb
2 Nov 22
Surgalign Announces Third Quarter 2022 Results and Provides Update on Business Operations and Financial Outlook
4:06pm